2025 SABCS Highlights: First-Line Tx for HER2+ Advanced Breast Cancer | Dana-Farber Cancer Institute
Автор: Dana-Farber Cancer Institute
Загружено: 2026-03-02
Просмотров: 238
Описание:
Harold Burstein, MD, PhD, and Sarah Sammons, MD, discuss the DESTINYBreast09, HER2-CLIMB, and PATINA CNS trials for first-line treatment in advanced breast cancer, which were presented at the 2025 San Antonio Breast Cancer Symposium.
For more information about Dana-Farber's Breast Oncology Center, visit https://www.dana-farber.org/cancer-ca...
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке: